Dr. Anecita P. Fadol earned her nursing diploma from the CLMMH School of Nursing and a Bachelor of Science in Nursing from Riverside College, Bacolod City, Philippines. Her academic journey continued with honors as she completed a Master of Science in Nursing specializing in Critical Care Nursing from the University Of Texas Health Science Center, Houston, Texas. Dr. Fadol further enriched her qualifications by attaining a Family Nurse Practitioner designation and a Doctor of Philosophy from Texas Woman's University, Houston, Texas.
Dr. Fadol has held significant roles, serving as the supervisor of the Critical Care Nursing Residency program and Clinical Nurse Specialist of the Cardiovascular Intensive Care Unit at The Methodist Hospital in Houston, Texas. Post Family Nurse Practitioner Program completion, she assumed the role of coordinator for the Heart Failure Program at Kelsey-Seybold Clinic, a prominent managed care system in Houston, Texas.
Dr. Fadol's research focuses on advancing symptom management for patients dealing with cancer and heart failure. Notably, she spearheaded the development and validation of the MD Anderson Symptom Inventory-Heart Failure (MDASI-HF) instrument for comprehensive symptom assessment. Her leadership extends to the coordination of the "Heart Success Program," a collaborative, interdisciplinary initiative dedicated to managing patients concurrently dealing with cancer and heart failure.
After completing the Family Nurse Practitioner Program, she was coordinator of the Heart Failure Program at Kelsey-Seybold Clinic, the largest managed care system in Houston, Texas. Dr Fadol's research focus is symptom management of patients with cancer and heart failure.
Dr. Fadol has been honored with the Oncology Nursing Society Nursing Research Fellowship award and was inducted as a Fellow of the American Academy of Nurse Practitioners. Notably, she serves as the editor of "Cardiac Complications of Cancer Therapy," a pioneering nursing reference textbook addressing the unique challenges faced by patients dealing with both cancer and cardiac issues.
